Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
Era Biology will host global live webinar at 30th June 2022 8:30 (GMT +08:00). The webinar will be in Spanish. The webinar will introduce the last technology for detecting invasive fungal disease. ...
FungiXpert Cryptococcal Antigen Rapid Test Successfully Approved by Health Canada
We are pleased to announce that our Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay) has b...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
The second National Academic Conference on Bacterial and Fungal Infections of Chinese Medical Association was successfully held in Guangzhou, July 29-31, 2022. The academic report of the conference...